Rich Pharmaceuticals, Inc. Retained Earnings
Rich Pharmaceuticals, Inc. had Retained Earnings of -$14.14 million as of 2018-03-31, per its 10-K filed 2018-07-17.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2018-07-17
- 2018-03-31: Retained Earnings (Accumulated Deficit) -$14.14M.
- 2017-12-31: Retained Earnings (Accumulated Deficit) -$12.90M.
- 2017-09-30: Retained Earnings (Accumulated Deficit) -$12.95M.
- 2017-06-30: Retained Earnings (Accumulated Deficit) -$14.75M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2018-03-31 | -$14.14M 10-K · filed 2018-07-17 | |
| 2017-12-31 | -$12.90M 10-Q · filed 2018-02-20 | |
| 2017-09-30 | -$12.95M 10-Q · filed 2017-12-29 | |
| 2017-06-30 | -$14.75M 10-Q · filed 2017-12-06 | |
| 2017-03-31 | -$12.44M 10-K · filed 2018-07-17 | |
| 2016-12-31 | -$10.19M 10-Q · filed 2017-02-13 | |
| 2016-09-30 | -$9.65M 10-Q · filed 2016-11-21 | |
| 2016-06-30 | -$9.38M 10-Q · filed 2016-08-22 | |
| 2016-03-31 | -$9.20M 10-K · filed 2017-09-05 | |
| 2015-12-31 | -$9.29M 10-Q · filed 2016-02-22 | |
| 2015-09-30 | -$8.39M 10-Q · filed 2015-11-23 | |
| 2015-06-30 | -$8.08M 10-Q · filed 2015-09-25 | |
| 2015-03-31 | -$7.43M 10-K · filed 2016-08-22 | |
| 2014-12-31 | -$5.93M 10-Q · filed 2015-02-25 | |
| 2014-09-30 | -$4.49M 10-Q · filed 2014-11-19 | |
| 2014-06-30 | -$3.82M 10-Q · filed 2014-08-19 | |
| 2014-03-31 | -$7.43M 10-Q · filed 2015-09-25 | -$3.30M 10-K · filed 2014-07-15 |
| 2013-12-31 | -$403.39K 10-Q · filed 2014-02-19 | |
| 2013-09-30 | -$259.47K 10-Q/A · filed 2014-01-17 | -$213.63K 10-Q · filed 2013-11-19 |
| 2013-06-30 | -$81.93K 10-Q/A · filed 2014-01-17 | -$89.96K 10-Q · filed 2013-08-19 |
| 2013-03-31 | -$81.93K 10-K · filed 2014-07-15 | |
| 2012-12-31 | -$65.93K 10-Q · filed 2013-02-01 | |
| 2012-09-30 | -$54.58K 10-Q · filed 2012-11-06 | |
| 2012-03-31 | -$50.58K 10-K · filed 2013-07-01 |